Skip to main content
Clinical Trials/IRCT20160523028008N23
IRCT20160523028008N23RecruitingPhase 2

Comparison of efficacy and safety of Levetiracetam and Phenobarbital in controlling neonatal seizures

Hamedan University of Medical Sciences0 sites40 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
1 day to 28 days (—)
Sex
All

Inclusion Criteria

  • Gestational age of 36 weeks or more
  • Weighing 2 kg or more
  • Occurrence of neonatal seizures between the first day and the 28th day after birth
  • Consent of the baby's parents or legal guardian

Exclusion Criteria

  • Receiving anti convulsion drugs in the last 72 hours
  • Seizures due to hypocalcemia, hypoglycemia, hypomagnesemia, and other electrolyte disorders
  • Serum creatinine level greater than 1.6 mg / d

Investigators

Similar Trials